AHA 22: SPYRAL HTN-ON MED: Renal Denervation in Patients with Hypertension | Dr David Kandzari

Journal Club - Dr N Odanovic - Spyral-HTN on Med Trial of Renal Denervation TherapyПодробнее

Renal Denervation for Hypertension: State of the Science in 2021Подробнее

Redefining hypertension management with renal denervation - EuroPCR 2021Подробнее

TCT 22: RADIANCE II Pivotal Trial: Paradise Renal Denervation System in Pts With HypertensionПодробнее

EuroPCR 2018: SPYRAL HTN-ON MED - Justin Davies, David KandzariПодробнее

TCT 22: SYMPLICITY HTN-3: RDN in Pts With Uncontrolled Hypertension | Dr Deepak BhattПодробнее

SPYRAL HTN-ON MED ResultsПодробнее

Hypertension management in 2022: Latest data on renal denervation from #EuroPCR 2022Подробнее

Hope for Hypertension: Ajay Kirtane, MD, on Sham-Controlled Renal DenervationПодробнее

Renal Denervation is Still AliveПодробнее

Renal Denervation: An Innovative New Treatment for High Blood PressureПодробнее

ACC 22: 3-year Efficacy Outcomes from the SPYRAL HTN-ON MED Med Pilot Study | Prof Felix MahfoudПодробнее

KCTV | Renal Denervation Helping Patients Combat HypertensionПодробнее

Radiofrequency Renal Denervation ProcedureПодробнее

Can renal denervation reduce cardiovascular events?Подробнее

SPYRAL HTN-ON MED 3 year resultsПодробнее